Clinical trial
The Effect of Opioids on P2Y12 Receptor Inhibition in Patients With ST-Elevation Myocardial Infarction Who Are Pre-treated With Crushed Ticagrelor
NCT03400267 is registered in ClinicalTrials.gov with A.H. Tavenier as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Opioids on P2Y12 Receptor Inhibition in Patients With ST-Elevation Myocardial Infarction Who Are Pre-treated With Crushed Ticagrelor
- Lead sponsor
- A.H. Tavenier
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 16, 2018
- Completion date
- November 22, 2019
- Enrollment
- 200 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
stemi, stemi - st elevation myocardial infarction